These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 25891965)

  • 1. An electronic nose in the discrimination of obese patients with and without obstructive sleep apnoea.
    Dragonieri S; Porcelli F; Longobardi F; Carratù P; Aliani M; Ventura VA; Tutino M; Quaranta VN; Resta O; de Gennaro G
    J Breath Res; 2015 Apr; 9(2):026005. PubMed ID: 25891965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exhaled breath profiling in patients with COPD and OSA overlap syndrome: a pilot study.
    Dragonieri S; Quaranta VN; Carratu P; Ranieri T; Resta O
    J Breath Res; 2016 Nov; 10(4):041001. PubMed ID: 27811380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evening and morning exhaled volatile compound patterns are different in obstructive sleep apnoea assessed with electronic nose.
    Kunos L; Bikov A; Lazar Z; Korosi BZ; Benedek P; Losonczy G; Horvath I
    Sleep Breath; 2015 Mar; 19(1):247-53. PubMed ID: 24840212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exhaled breath profiling by electronic nose enabled discrimination of allergic rhinitis and extrinsic asthma.
    Dragonieri S; Quaranta VN; Carratu P; Ranieri T; Resta O
    Biomarkers; 2019 Feb; 24(1):70-75. PubMed ID: 30074408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smelling the Diagnosis: The Electronic Nose as Diagnostic Tool in Inflammatory Arthritis. A Case-Reference Study.
    Brekelmans MP; Fens N; Brinkman P; Bos LD; Sterk PJ; Tak PP; Gerlag DM
    PLoS One; 2016; 11(3):e0151715. PubMed ID: 26982569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Editor's Highlight: Prospective Analyses of Volatile Organic Compounds in Obstructive Sleep Apnea Patients.
    Aoki T; Nagaoka T; Kobayashi N; Kurahashi M; Tsuji C; Takiguchi H; Tomomatsu K; Oguma T; Kobayashi N; Magatani K; Takeda S; Asano K; Abe T
    Toxicol Sci; 2017 Apr; 156(2):362-374. PubMed ID: 28003437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma.
    Fens N; Zwinderman AH; van der Schee MP; de Nijs SB; Dijkers E; Roldaan AC; Cheung D; Bel EH; Sterk PJ
    Am J Respir Crit Care Med; 2009 Dec; 180(11):1076-82. PubMed ID: 19713445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An electronic nose distinguishes exhaled breath of patients with Malignant Pleural Mesothelioma from controls.
    Dragonieri S; van der Schee MP; Massaro T; Schiavulli N; Brinkman P; Pinca A; Carratú P; Spanevello A; Resta O; Musti M; Sterk PJ
    Lung Cancer; 2012 Mar; 75(3):326-31. PubMed ID: 21924516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrafast gas chromatography coupled to electronic nose to identify volatile biomarkers in exhaled breath from chronic obstructive pulmonary disease patients: A pilot study.
    Rodríguez-Aguilar M; Ramírez-García S; Ilizaliturri-Hernández C; Gómez-Gómez A; Van-Brussel E; Díaz-Barriga F; Medellín-Garibay S; Flores-Ramírez R
    Biomed Chromatogr; 2019 Dec; 33(12):e4684. PubMed ID: 31423612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of age and gender on the profile of exhaled volatile organic compounds analyzed by an electronic nose.
    Dragonieri S; Quaranta VN; Carratu P; Ranieri T; Resta O
    J Bras Pneumol; 2016 Apr; 42(2):143-5. PubMed ID: 27167436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD.
    Dragonieri S; Annema JT; Schot R; van der Schee MP; Spanevello A; Carratú P; Resta O; Rabe KF; Sterk PJ
    Lung Cancer; 2009 May; 64(2):166-70. PubMed ID: 18834643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exhaled biomarker pattern is altered in children with obstructive sleep apnoea syndrome.
    Benedek P; Lázár Z; Bikov A; Kunos L; Katona G; Horváth I
    Int J Pediatr Otorhinolaryngol; 2013 Aug; 77(8):1244-7. PubMed ID: 23746417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electronic nose based analysis of exhaled volatile organic compounds spectrum reveals asthmatic shifts and consistency in controls post-exercise and spirometry.
    Dragonieri S; Marco MD; Ahroud M; Quaranta VN; Portacci A; Iorillo I; Montagnolo F; Carpagnano GE
    J Breath Res; 2024 Jun; 18(3):. PubMed ID: 38876093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exhaled volatile organic compounds analysis by e-nose can detect idiopathic pulmonary fibrosis.
    Dragonieri S; Scioscia G; Quaranta VN; Carratu P; Venuti MP; Falcone M; Carpagnano GE; Foschino Barbaro MP; Resta O; Lacedonia D
    J Breath Res; 2020 Jul; 14(4):047101. PubMed ID: 32320958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An electronic nose in the discrimination of patients with asthma and controls.
    Dragonieri S; Schot R; Mertens BJ; Le Cessie S; Gauw SA; Spanevello A; Resta O; Willard NP; Vink TJ; Rabe KF; Bel EH; Sterk PJ
    J Allergy Clin Immunol; 2007 Oct; 120(4):856-62. PubMed ID: 17658592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic and airway inflammation in sleep apnea and obesity: the role of ICAM-1 and IL-8.
    Carpagnano GE; Spanevello A; Sabato R; Depalo A; Palladino GP; Bergantino L; Foschino Barbaro MP
    Transl Res; 2010 Jan; 155(1):35-43. PubMed ID: 20004360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electronic nose in discrimination of children with uncontrolled asthma.
    Tenero L; Sandri M; Piazza M; Paiola G; Zaffanello M; Piacentini G
    J Breath Res; 2020 Jul; 14(4):046003. PubMed ID: 32512553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electronic Nose Technology in Respiratory Diseases.
    Dragonieri S; Pennazza G; Carratu P; Resta O
    Lung; 2017 Apr; 195(2):157-165. PubMed ID: 28238110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expiratory flow rate, breath hold and anatomic dead space influence electronic nose ability to detect lung cancer.
    Bikov A; Hernadi M; Korosi BZ; Kunos L; Zsamboki G; Sutto Z; Tarnoki AD; Tarnoki DL; Losonczy G; Horvath I
    BMC Pulm Med; 2014 Dec; 14():202. PubMed ID: 25510554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of exhaled volatile organic compounds analysis using electronic nose as index of COPD severity.
    Finamore P; Pedone C; Scarlata S; Di Paolo A; Grasso S; Santonico M; Pennazza G; Antonelli Incalzi R
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1441-1448. PubMed ID: 29750030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.